What is Sun Pharma Laboratories investing in?

Sun Pharma Laboratories is investing in a new greenfield formulations manufacturing facility in Madhya Pradesh.

How much is Sun Pharma investing in Madhya Pradesh?

Sun Pharma is investing Rs 3,000 crore in the new manufacturing plant.

Where will Sun Pharma's new plant be located?

The new manufacturing plant will be located in Madhya Pradesh, India.

Home / Business and Economy / Sun Pharma Invests ₹3,000 Crore in New MP Plant

Sun Pharma Invests ₹3,000 Crore in New MP Plant

3 Dec, 2025

•

Summary

Sun Pharma subsidiary plans a new manufacturing plant.
The investment earmarked for the new facility is Rs 3,000 crore.
The plant will be established in Madhya Pradesh.

Sun Pharma Invests ₹3,000 Crore in New MP Plant

Sun Pharmaceutical Industries, through its wholly-owned subsidiary Sun Pharma Laboratories Ltd, has announced plans for a substantial investment in India. The company's board has approved a proposal to establish a greenfield formulations manufacturing facility in Madhya Pradesh, signaling a major commitment to expanding its production capabilities.

This new venture represents a significant financial outlay, with an estimated investment of Rs 3,000 crore dedicated to the construction and operationalization of the plant. The strategic location in Madhya Pradesh is expected to bolster Sun Pharma's manufacturing footprint and contribute to its growth objectives within the pharmaceutical sector.

The announcement coincided with a positive market performance for Sun Pharma, whose shares closed at Rs 1,805.70 on the BSE, marking a 0.43% increase. This investment highlights the company's confidence in the Indian market and its ongoing strategy to enhance its domestic manufacturing infrastructure.